Literature DB >> 453877

Plasmapheresis and immunosuppressive therapy. Effect on levels of intercellular antibodies in pemphigus vulgaris.

R Auerbach, J C Bystryn.   

Abstract

A patient with pemphigus vulgaris and serious side effects of steroid therapy was treated by exchange plasmapheresis. Eight plasmaphereses were performed over six weeks. Each procedure reduced the serum level of intercellular antibodies by 50% to 87%. A rebound in levels of intercellular antibodies usually followed their depletion but could be minimized or completely suppressed by administration of cyclophosphamide. After six weeks of therapy, clinical symptoms had greatly improved and intercellular antibody levels had decreased from a titer of 5,120 to 160. It is not possible to ascribe these improvements specifically to plasmapheresis since the patient was concurrently receiving low doses of prednisone and intermittent treatment with cyclophosphamide.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 453877     DOI: 10.1001/archderm.115.6.728

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  4 in total

1.  Pemphigus vulgaris and plasma exchange. Role of intercellular antibodies.

Authors:  D W Johnson; T L Simon; W G Chapman
Journal:  West J Med       Date:  1983-11

2.  Pemphigus.

Authors: 
Journal:  West J Med       Date:  1983-05

3.  Plasmapheresis in the initial treatment of insulin-dependent diabetes mellitus in children.

Authors:  J Ludvigsson; L Heding; G Liedén; B Marner; A Lernmark
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-15

4.  Fully human monoclonal antibody inhibitors of the neonatal fc receptor reduce circulating IgG in non-human primates.

Authors:  Andrew E Nixon; Jie Chen; Daniel J Sexton; Arumugam Muruganandam; Alan J Bitonti; Jennifer Dumont; Malini Viswanathan; Diana Martik; Dina Wassaf; Adam Mezo; Clive R Wood; Joseph C Biedenkapp; Chris TenHoor
Journal:  Front Immunol       Date:  2015-04-23       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.